期刊文献+

以呼吸障碍为突出表现的Ⅱ型糖元累积病21例分析 被引量:4

Respiratory failure as the prominent manifestation in glycogen storage disease type Ⅱ
暂未订购
导出
摘要 目的探讨以呼吸障碍为突出表现的Ⅱ型糖元累积病的临床和病理学特点。方法对2例以呼吸障碍为突出表现的Ⅱ型糖元累积病的病例进行了临床及病理学观察。结果2例病例均在病程的早期即发生呼吸衰竭,例1出现四肢近端肌无力,而例2四肢远、近端肌肉均无力。治疗效果较差,长期不能脱离呼吸机的支持。肌酶谱轻、中度升高,肌电图提示运动单位电位时程缩短、波幅降低,部分被检肌肉可见纤颤电位和复杂重复放电活动。肌肉病理学改变为空泡性肌病,PAS染色显示肌纤维普遍深染,部分肌纤维内有小颗粒或块状深染物质,可被唾液淀粉酶完全消化。酸性磷酸酶染色可见空泡样改变的肌纤维明显深染。电镜显示肌细胞的溶酶体内和胞浆内糖原聚集。结论青少年患者出现四肢肌无力,早期发生的呼吸衰竭,而且长期不能脱离呼吸机,应该考虑Ⅱ型糖元累积病的可能,肌肉活检病理学分析是诊断的关键所在。 Objective To study clinical and pathological features of glycogen storage disease type Ⅱ (GSD Ⅱ) predominantly presented with respiratory failure. Methods The clinical and pathological study in 2 cases of GSD Ⅱpredominantly presented with respiratory failure have been performed. Results Two cases of GSD Ⅱpresented with respiratory failure in early stage of the course, case 1 had proximal muscle weakness, while case 2 had both proximal and distal muscle weakness. The effect of therapy was disappointed and the patients could not be taken off respiratory support. The serum CK level rose mildly or moderately. The EMG revealed shortened time course and decreased amplitude of motor unit potential, some muscle associated with abundant fibrillation potential or complex repetitive discharges. Muscle biopsy demonstrated vacuolar myopathy, PAS stain revealed dark-staining, coarse, granular inclusions in the cytoplasm of the myocytes and digestible by diastase, acid phosphatase stain showed dark-staining in vacuolar myocytes. Electron microscopic examination showed glycogen storage within lysosomes and free glycogen in the cytoplasm. Conclusions Adolescent patients presented with muscle weakness in extremities and respiratory failure in early stage of the course, and who must use respiratory support for a long runs, should be considered as GDS If. Muscle biopsy is the key procedure for confirming diagnosis.
出处 《中国神经精神疾病杂志》 CAS CSCD 北大核心 2007年第10期581-584,共4页 Chinese Journal of Nervous and Mental Diseases
关键词 呼吸衰竭 Ⅱ型糖元累积病 肌肉病理学 Respiratory failure Glycogen storage disease type Ⅱ Muscle pathology
  • 相关文献

参考文献11

  • 1Martiniuk F, Mehler M, Tzall S, et al. Sequence of the cDNA and 5'-flanking region for human acid alpha-glucosidase, detection of an intron in the 5' untranslated leader sequence, definition of 18-bp polymorphisms, and differences with previous cDNA and amino acid sequences. DNA Cell Biol, 1990, 9(2) :85.
  • 2Engel A, Hirschhorn R. Acid maltase deficiency. In: Engel A, Banker B. Myology. New York: McGraw-Hill,1994. 1533 - 1553.
  • 3Martin JJ, de Barsy T, Van Hoof F, et al. Pompe's disease: an inborn lysosomal disorder with storage of glycogen. A study of brain and striated muscle. Acta Neuropathol ( Berl), 1973, 23 ( 2 ) :229.
  • 4Martini C, Ciana G, Benettoni A, et al. Intractable fever and cortical neuronal glycogen storage in glycogenosis type 2. Neurology, 2001,57 (5) :906
  • 5Tein I. Metabolic myopathies. Semin Pediatric Neurol, 1996, 3 (2) : 59.
  • 6Mellies U, Ragette R, Schwake C, et al. Sleep-disordered breathing and respiratory failure in acid maltase deficiency. Neurology, 2001, 57(7) :1290.
  • 7Basil TD, Neil RF. Metabolic myopathies: a clinical approach; part Ⅱ. Pediatr Neurol, 2000, 22(3) :171.
  • 8Slonim AE, Coleman RA, McElligot MA, et al. Improvement of muscle function in acid maltase deficiency by high-protein therapy. Neurology, 1983(33) :34.
  • 9Margolis M, Hill A. Acid maltase deficiency in an adult: Evidence for improvement in respiratory function with high-protein dietary therapy. Am Rev Resp Dis, 1986(134) :328.
  • 10Nicolino MP, Puech JP, Kremer El, et al. Adenovirus-mediated transfer of the acid alpha-glucosidase gene into fibroblasts, myoblasts and myotubes from patients with glycogen storage disease type Ⅱ leads to high level expression of enzyme and corrects glycogen accumulation. Hum Mol Genet, 1998(7) : 1695.

同被引文献132

  • 1陈琳,郭玉璞,任海涛,赵燕环,关鸿志,管宇宙,彭斌,刘大为.少年起病的Ⅱ型糖原累积病五例临床病理研究[J].中华神经科杂志,2005,38(1):51-54. 被引量:16
  • 2傅立军,窦薇,周爱卿,黄美蓉,杨健萍,李奋.糖原累积病Ⅱ型的临床分析和基因学检测[J].临床儿科杂志,2006,24(12):962-965. 被引量:12
  • 3Fukuda T, Ewan L, Bauer M, et al. Dysfunction of endocytic and autophagic pathways in a lysosomal storage disease. Ann Neurol, 2006, 59 : 700-708.
  • 4Raben N, Baum R, Schreiner C, et al. Genetic suppression of autophagy dramatically enhances enzyme replacement therapy in murine Pompe disease. Clin Ther, 2010, 32(Suppl B) : S62.
  • 5Kishnani PS, Hwu WL, Mandel H, et al. A retrospective, multinational, multicenter study on the natural history of infantileonset Pompe disease. J Pediatr, 2006, 148 : 671-676.
  • 6Laforet P, Nicolino M, Eymard PB, et al. Juvenile and adult onset acid maltase deficiency in France: genotype-phenotype correlation. Neurology, 2000, 55 : 1122-1128.
  • 7Laforet P, Petiot P, Nieolino M, et al. Dilative arteriopathy and basilar artery dolichoectasia complicating late-onset Pompe disease. Neurology, 2008,70 : 2063-2066.
  • 8Katzin LW, Amato AA. Pompe disease: a review of the current diagnosis and treatment recommendations in the era of enzyme replacement therapy. J Clin Neuromuscul Dis, 2008,9: 421-431.
  • 9van den Hout HM, Hop W, van Diggelen OP, et al. The natural course of infantile Pompe' s disease : 20 original cases compared with 133 cases from the literature. Pediatrics, 2003, 112: 332- 340.
  • 10Labrousse P, Chien YH, Pomponio RJ et al. Genetic heterozygosity and pseudodefieiency in the Pompe disease newborn screening pilot program. Mol Genet Metab, 2010, 99: 379-383.

引证文献4

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部